ICH Q10 - Pharmaceutical Quality System

What it says

A comprehensive pharmaceutical quality system model spanning the full product lifecycle, integrating process performance and product quality monitoring, a CAPA system, change management, and management review, built on top of, and in addition to, applicable regional GMP requirements.

Paraphrased for plain-language clarity. Always verify against the current published regulation text.

What it means in practice

• ICH Q10 does not replace regional GMP requirements such as 21 CFR Part 211 or EU GMP Chapters - it sits on top of them, describing how the individual required systems should function together as one coherent whole.
• The management review element specifically expects senior management to receive and act on quality system performance data, not just receive summary reports for information.
• Knowledge management and quality risk management are described as enablers running through every other element of the system, not as standalone activities disconnected from daily operations.

What inspectors look for

• Whether individual required systems, CAPA, change control, deviation management, complaint handling, actually connect and inform each other, or exist as isolated compliance activities.
• Whether management review meetings show evidence of genuine engagement with quality data and follow-up action, rather than a passive information-sharing exercise.
• Whether quality risk management principles are visibly applied to real operational decisions, rather than existing only within formal risk assessment documents.

Related regulations